Award
Delivery Order #SPE2DR26F3XQE
Delivery Order for Diabetes Medication under Long-Term Pharmaceutical IDV
Buyer
Defense Logistics Agency
Award Amount
$245.44
Ceiling
$245.44
Awarded
March 09, 2026
Period of Performance
Mar 09, 2026 – Mar 10, 2026
Identifier
SPE2DR26F3XQE
NAICS
424210
This is a definitive delivery order contract awarded to AmerisourceBergen Drug Corporation, a leading pharmaceutical distributor, under an existing Indefinite Delivery Vehicle (IDV) for pharmaceutical products. The contract procures Tresiba FlexTouch insulin, a specialized diabetes medication, highlighting the agency's commitment to providing essential healthcare products. The work involves timely delivery of this insulin product to support ongoing medical treatment needs. This award is a small but vital supplement to the larger IDV contract that AmerisourceBergen holds, reinforcing its role in federal pharmaceutical logistics. The contract was most likely awarded under a competitive process as part of the IDV requirements and has a brief performance window in early 2026. The contract supports federal healthcare supply chains by ensuring reliable medication availability. There are no key subcontractors or prior specific solicitations disclosed for this delivery order.
Description
4571086416!TRESIBA FLEXTOUCH 100 UNIT/ML 3ML